Cadherin-3 is a novel oncogenic biomarker with prognostic value in glioblastoma.

Saved in:

Bibliographic Details
Title:	Cadherin-3 is a novel oncogenic biomarker with prognostic value in glioblastoma.
Authors:	Martins EP; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.; ICVS/3B's - PT Government Associate Laboratory, Braga/Guimarães, Portugal., Gonçalves CS; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.; ICVS/3B's - PT Government Associate Laboratory, Braga/Guimarães, Portugal., Pojo M; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.; ICVS/3B's - PT Government Associate Laboratory, Braga/Guimarães, Portugal., Carvalho R; i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal., Ribeiro AS; i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal., Miranda-Gonçalves V; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.; ICVS/3B's - PT Government Associate Laboratory, Braga/Guimarães, Portugal., Taipa R; Neuropathology Unit, Department of Neurosciences, Centro Hospitalar do Porto, Porto, Portugal., Pardal F; Department of Pathology, Hospital de Braga, Portugal., Pinto AA; Department of Neurosurgery, Hospital de Braga, Portugal., Custódia C; Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Portugal., Faria CC; Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Portugal.; Neurosurgery Department, Hospital de Santa Maria, Centro Hospitalar Lisboa Norte (CHLN), Portugal., Baltazar F; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.; ICVS/3B's - PT Government Associate Laboratory, Braga/Guimarães, Portugal., Sousa N; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.; ICVS/3B's - PT Government Associate Laboratory, Braga/Guimarães, Portugal., Paredes J; i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.; Faculty of Medicine of the University of Porto, Portugal., Costa BM; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.; ICVS/3B's - PT Government Associate Laboratory, Braga/Guimarães, Portugal.
Source:	Molecular oncology [Mol Oncol] 2022 Jul; Vol. 16 (14), pp. 2611-2631. Date of Electronic Publication: 2022 Jun 10.
Publication Type:	Journal Article; Research Support, Non-U.S. Gov't
Journal Info:	Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1878-0261
DOI:	10.1002/1878-0261.13162